SEC Form 5 · accession 0000899243-18-004076
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George F Tidmarsh
Officer — President, CEO & Secretary · Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 14, 2018 · 9:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 2, 2017 | G | 71,400 | $0.00 | D | 1,282,686 | D | |
| Common Stock | Oct 5, 2017 | G | 2,000 | $0.00 | D | 1,282,686 | D | |
| Common Stock | holding | — | — | — | 22,000 | I | By Children |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents bona fide gifts to two not-for-profit charitable entities
- F2Represents a bona fide gift to a not-for-profit charitable entity